Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
Study NCT ID:
NCT07464366
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-11
First Post:
2025-09-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Safety and Efficacy of MRG003 With or Without Putrelimab in Recurrent or Metastatic Salivary Gland Cancer: a Single-center, Open-label Cohort Study
Sponsor:
Ji Dongmei
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-03-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-05-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-30
First Submit QC Date:
None
Study First Post Date:
2026-03-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-10
Last Update Post Date:
2026-03-11
Last Update Post Date Type:
ACTUAL